Intra-Cellular Therapies Inc. buy Royal Bank of Canada
Start price
03.11.23
/
50%
€51.40
Target price
03.11.24
€70.83
Performance (%)
31.32%
Price
02.05.24
€66.00
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Intra-Cellular Therapies Inc. has seen massive gains of 31.32%. This prediction currently runs until 03.11.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intra-Cellular Therapies Inc. | -2.222% | -2.222% |
| iShares Core DAX® | 0.000% | -2.064% |
| iShares Nasdaq 100 | 0.626% | -2.884% |
| iShares Nikkei 225® | 1.568% | -5.892% |
| iShares S&P 500 | 0.334% | -2.281% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target lowered by analysts at Royal Bank of Canada from $77.00 to $76.00. They now have an "outperform" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€62.50
03.04.24
03.04.24
€79.68
03.04.25
03.04.25
5.60%
02.05.24
02.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.80
23.02.24
23.02.24
€79.43
23.02.25
23.02.25
1.85%
02.05.24
02.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.60
31.01.24
31.01.24
€79.15
31.01.25
31.01.25
3.77%
02.05.24
02.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€53.50
04.08.23
04.08.23
€71.56
04.08.24
04.08.24
23.36%
02.05.24
02.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€44.00
02.03.23
02.03.23
€67.06
02.03.24
02.03.24
50.68%
03.03.24
03.03.24